CClinicalTrials.gg
CompletedNCT01091935Updated Mar 24, 2010

Safety of Intravenous Lidocaine Infusions

An observational study in Neuropathic Pain, sponsored by London Health Sciences Centre Research Institute and Lawson Research Institute of St. Joseph's. Completed at 1 site in Canada. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2010-03-24.

Sponsored by London Health Sciences Centre Research Institute and Lawson Research Institute of St. Joseph's · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
70
Ages
18 Years to 80 Years
Sex
All
01

Study summary

The purpose of this study is to prospectively determine the side effects profile in adults with neuropathic pain receiving intravenous infusions of lidocaine 5 mg per kg of lean body weight, infused over 45 minutes.

Read the detailed description

Eligibility Criteria:

Adults > 18 yrs with chronic central or peripheral neuropathic pain at the St Joseph's Health Care Pain Clinic between June and December 2009.

Outcome measures: All side effects spontaneously reported. Sedation, nausea, dizziness by Visual Analog Score Q 15 minutes; hemodynamic data q 5 minutes during and after infusion for 30 minutes.

Daily diary of side effects and Visual Analogue score of Pain for 7 days post-infusion.

02

Conditions studied

  • Neuropathic Pain

Browse trials for

Keywords

  • Lidocaine,Intravenous Infusions,Neuropathic Pain,Side Effects
03

In context

Neuralgia

1,287 studies on the registry are indexed under Neuralgia; 256 are open to participants now.

This study's enrollment of 70 is below the median of 100 across 260 observational studies indexed under Neuralgia.

Browse Neuralgia studies →

Lead sponsor

London Health Sciences Centre Research Institute and Lawson Research Institute of St. Joseph's is the lead sponsor of 352 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Adult outpatients attending St Joseph's Chronic Pain Clinic in one of two time periods who have been diagnosed with chronic neuropathic pain by clinical history and examination and are scheduled to receive a lidocaine infusion for pain management

Inclusion criteria

  • Adult outpatients > 18 years \< 80 years diagnosed with chronic neuropathic pain

Exclusion criteria

Exclusion Criteria:

  • Unable to provide informed consent
  • Unable to speak and understand English
  • Liver, kidney, or cardiac failure
  • Allergy to Lidocaine
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
70 participants (actual)

Groups and cohorts

  • Lidocaine

    Adults \>18 yrs , attending St Joseph's Health Care Pain Clinic with a diagnosis of chronic neuropathic pain who are being treated with an lidocaine infusion of 5 mg/kg over 45 minutes Consecutive patients from two time periods: 1. June 15 to August 21, 2009 2. October 15-Dec 22,2009

06

Study locations

1 site
  • St Joseph's Health Care
    London, Ontario N6A 4V2, Canada
07

References and documents

Publications

  • Attal N, Gaude V, Brasseur L, Dupuy M, Guirimand F, Parker F, Bouhassira D. Intravenous lidocaine in central pain: a double-blind, placebo-controlled, psychophysical study. Neurology. 2000 Feb 8;54(3):564-74. doi: 10.1212/wnl.54.3.564. PubMed 10680784 ↗
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 24, 2010, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01091935
Lead sponsor
London Health Sciences Centre Research Institute and Lawson Research Institute of St. Joseph's
Collaborators
University of Western Ontario, Canada
First posted
Mar 24, 2010
Start date
Jun 2009
Primary completion
Jan 2010
Completion
Jan 2010
Last update
Mar 24, 2010

Study contacts

Patricia K Morley-Forster, MD, FRCPC
principal investigator · Associate Professor,Dept of Anesthesia and Perioperative Medicine,University of Western Ontario, Lawson Health Research Institute
Patricia K Morley-Forster, MD, FRCPC
principal investigator · Associate Professor, University of Western Ontario, Lawson Health Research Institute

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2010. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion